138 related articles for article (PubMed ID: 35296440)
1. ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma.
Xu X; Wang B; Liu Y; Jing T; Xu G; Zhang L; Kun Jiao ; Chen Z; Xiang L; Xu C; Yang Z; Liu Y
Cancer Lett; 2022 Jul; 537():215640. PubMed ID: 35296440
[TBL] [Abstract][Full Text] [Related]
2. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
[TBL] [Abstract][Full Text] [Related]
4. ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
Su H; Shu S; Tang W; Zheng C; Zhao L; Fan H
Biochem Biophys Res Commun; 2023 Dec; 684():149137. PubMed ID: 37897911
[TBL] [Abstract][Full Text] [Related]
5. TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.
Zhang J; Liu P; Tao J; Wang P; Zhang Y; Song X; Che L; Sumazin P; Ribback S; Kiss A; Schaff Z; Cigliano A; Dombrowski F; Cossu C; Pascale RM; Calvisi DF; Monga SP; Chen X
Am J Pathol; 2019 May; 189(5):1077-1090. PubMed ID: 30794805
[TBL] [Abstract][Full Text] [Related]
6. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
[No Abstract] [Full Text] [Related]
8. Upregulated YAP promotes oncogenic CTNNB1 expression contributing to molecular pathology of hepatoblastoma.
Lu S; Jiang M; Chen Q; Luo X; Cao Z; Huang H; Zheng M; Du J
Pediatr Blood Cancer; 2022 Sep; 69(9):e29705. PubMed ID: 35404538
[TBL] [Abstract][Full Text] [Related]
9. Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.
Tschaharganeh DF; Chen X; Latzko P; Malz M; Gaida MM; Felix K; Ladu S; Singer S; Pinna F; Gretz N; Sticht C; Tomasi ML; Delogu S; Evert M; Fan B; Ribback S; Jiang L; Brozzetti S; Bergmann F; Dombrowski F; Schirmacher P; Calvisi DF; Breuhahn K
Gastroenterology; 2013 Jun; 144(7):1530-1542.e12. PubMed ID: 23419361
[TBL] [Abstract][Full Text] [Related]
10. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis.
Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of YAP, TAZ, TEAD4 and p73 in human laryngeal cancer.
Tsinias G; Nikou S; Mastronikolis N; Bravou V; Papadaki H
Histol Histopathol; 2020 Sep; 35(9):983-995. PubMed ID: 32378727
[TBL] [Abstract][Full Text] [Related]
12. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
13. YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
Thomann S; Weiler SME; Marquard S; Rose F; Ball CR; Tóth M; Wei T; Sticht C; Fritzsche S; Roessler S; De La Torre C; Ryschich E; Ermakova O; Mogler C; Kazdal D; Gretz N; Glimm H; Rempel E; Schirmacher P; Breuhahn K
Cancer Res; 2020 Dec; 80(24):5502-5514. PubMed ID: 33087321
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-α signaling.
Qi D; Lu M; Xu P; Yao X; Chen Y; Gan L; Li Y; Cui Y; Tong X; Liu S; Zhao J; Liu N; Ye X
Cancer Commun (Lond); 2023 Dec; 43(12):1354-1372. PubMed ID: 37670477
[TBL] [Abstract][Full Text] [Related]
15. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
16. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
[TBL] [Abstract][Full Text] [Related]
17. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
[TBL] [Abstract][Full Text] [Related]
18. CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis.
Guo Y; Zhu Z; Huang Z; Cui L; Yu W; Hong W; Zhou Z; Du P; Liu CY
Nat Commun; 2022 Aug; 13(1):4995. PubMed ID: 36008411
[TBL] [Abstract][Full Text] [Related]
19. [YAP induces chromosomal instability in liver cancer patients].
Weiler S
Pathologe; 2018 Dec; 39(Suppl 2):185-188. PubMed ID: 30206654
[TBL] [Abstract][Full Text] [Related]
20. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.
Gu Y; Ding C; Yu T; Liu B; Tang W; Wang Z; Tang X; Liang G; Peng J; Zhang X; Li Z
Cancer Sci; 2024 Apr; 115(4):1209-1223. PubMed ID: 38288904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]